Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression

Cogito Health

Status: Completed

Conditions: Bipolar Disorder; Depression

Treatments: Other: Cogito Companion Mobile Phone Application

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02742064

1R44MH107065-01

Details and patient eligibility

About

The purpose of this study is to determine if a mobile sensing platform can passively and objectively detect the presence of clinically significant mood disorder symptomatology and symptom progression over time. Meeting this goal will allow for improved risk categorization, prediction of relapse, and measurement of disease progression in a lifetime prevalence population.

Enrollment: 899 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 18 or older
• Have a smartphone and cell service plan, including voice and data, that meets the device requirements of the Mobile Sensing Platform.
• Enrolled in the MoodNetwork

Exclusion criteria

• Report positively on the QIDS-SR suicide item during study intake
• Total score greater than 15 on the QIDS-SR during the screening process

Trial design

899 participants in 3 patient groups

MDD-Single Episode

Description:

1. Subjects who have experienced 1 episode of major depressive disorder (MDD) in their lifetime.

Treatment:

Other: Cogito Companion Mobile Phone Application

MDD-Recurrent

Description:

1. Subjects who have experienced 2 or more episodes of depressive disorder (MDD) in their lifetime.

Treatment:

Other: Cogito Companion Mobile Phone Application

Bipolar Disorder

Description:

1. Subjects who have been diagnosed with bipolar disorder in their lifetime.

Treatment:

Other: Cogito Companion Mobile Phone Application